Your browser doesn't support javascript.
loading
Bone Morphogenetic Protein 9 Is a Mechanistic Biomarker of Portopulmonary Hypertension.
Nikolic, Ivana; Yung, Lai-Ming; Yang, Peiran; Malhotra, Rajeev; Paskin-Flerlage, Samuel D; Dinter, Teresa; Bocobo, Geoffrey A; Tumelty, Kathleen E; Faugno, Anthony J; Troncone, Luca; McNeil, Megan E; Huang, Xiuli; Coser, Kathryn R; Lai, Carol S C; Upton, Paul D; Goumans, Marie Jose; Zamanian, Roham T; Elliott, C Gregory; Lee, Arthur; Zheng, Wei; Berasi, Stephen P; Huard, Christine; Morrell, Nicholas W; Chung, Raymond T; Channick, Richard W; Roberts, Kari E; Yu, Paul B.
Afiliación
  • Nikolic I; 1 Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Yung LM; 1 Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Yang P; 1 Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Malhotra R; 2 Division of Cardiology.
  • Paskin-Flerlage SD; 1 Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Dinter T; 1 Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Bocobo GA; 1 Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Tumelty KE; 3 Pfizer Centers for Therapeutic Innovation, Cambridge, Massachusetts.
  • Faugno AJ; 4 Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Tufts Medical Center, Boston, Massachusetts.
  • Troncone L; 1 Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • McNeil ME; 1 Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Huang X; 5 Therapy for Rare and Neglected Diseases Program, National Center for Advancing Translational Sciences, Rockville, Maryland.
  • Coser KR; 3 Pfizer Centers for Therapeutic Innovation, Cambridge, Massachusetts.
  • Lai CSC; 1 Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Upton PD; 6 Division of Respiratory Medicine, Department of Medicine, University of Cambridge School of Clinical Medicine, Addenbrooke's and Papworth Hospitals, Cambridge, United Kingdom.
  • Goumans MJ; 7 Department of Molecular Cell Biology and Cancer Genomics Centre Netherlands, Leiden University Medical Centre, Leiden, the Netherlands.
  • Zamanian RT; 8 Division of Pulmonary and Critical Care Medicine, Department of Medicine, Stanford University Medical Center, Stanford, California; and.
  • Elliott CG; 9 Department of Medicine, Intermountain Medical Center and University of Utah, Salt Lake City, Utah.
  • Lee A; 5 Therapy for Rare and Neglected Diseases Program, National Center for Advancing Translational Sciences, Rockville, Maryland.
  • Zheng W; 5 Therapy for Rare and Neglected Diseases Program, National Center for Advancing Translational Sciences, Rockville, Maryland.
  • Berasi SP; 3 Pfizer Centers for Therapeutic Innovation, Cambridge, Massachusetts.
  • Huard C; 3 Pfizer Centers for Therapeutic Innovation, Cambridge, Massachusetts.
  • Morrell NW; 6 Division of Respiratory Medicine, Department of Medicine, University of Cambridge School of Clinical Medicine, Addenbrooke's and Papworth Hospitals, Cambridge, United Kingdom.
  • Chung RT; 10 Gastrointestinal Unit and Liver Center, and.
  • Channick RW; 11 Division of Pulmonary and Critical Care Medicine, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
  • Roberts KE; 4 Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Tufts Medical Center, Boston, Massachusetts.
  • Yu PB; 1 Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Am J Respir Crit Care Med ; 199(7): 891-902, 2019 04 01.
Article en En | MEDLINE | ID: mdl-30312106
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Morfogenéticas Óseas / Hipertensión Portal / Hipertensión Pulmonar / Hepatopatías Tipo de estudio: Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Respir Crit Care Med Asunto de la revista: TERAPIA INTENSIVA Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Morfogenéticas Óseas / Hipertensión Portal / Hipertensión Pulmonar / Hepatopatías Tipo de estudio: Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Respir Crit Care Med Asunto de la revista: TERAPIA INTENSIVA Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos